$51.90
-0.55 (-1.05%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+4.43%
1Y
-7.26%
YTD
-3.48%
Open$52.55
Previous Close$52.45
Day High$53.11
Day Low$51.51
52W High$78.48
52W Low$44.12
Volume—
Avg Volume1.69M
Market Cap4.64B
P/E Ratio—
EPS$-6.21
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$54.19
Below
SMA 200
$54.12
Below
RSI (14)
52.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
32 analysts
Price Target
+114.0% upside
Current
$51.90
$51.90
Target
$111.08
$111.08
$83.97
$111.08 avg
$162.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.77M | 2.64M | 1.10B |
| Net Income | -625,611,931 | -393,714,242 | -133,819,624 |
| Profit Margin | -16,569.8% | -15,741.3% | -12.2% |
| EBITDA | -693,913,092 | -460,958,980 | -179,167,841 |
| Free Cash Flow | — | — | -115,939,335 |
| Rev Growth | +43.0% | +43.0% | +24.0% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |